Crossmark

Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis

Crossref DOI link: https://doi.org/10.1016/j.neurop.2024.100148

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Anabel, Z.F.

Gema, M.A.

Bonaventura, C.E.

Judith, P.R.
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-02-03
More Information

This article is maintained by: Elsevier

Article Title: Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis

Journal Title: Neurology Perspectives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neurop.2024.100148

Content Type: article

Copyright: © 2024 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.